《新股表現》康德萊醫械(01501.HK)暗盤收報25.75元 高上市價23.8%
根據輝立交易平台顯示,明天掛牌的康德萊醫療器械(01501.HK)暗盤高開逾16%報24.2元,最多漲24.8%高見25.95元,收報25.75元,較上市價20.8元,高23.8%或4.95元,成交402萬股,涉資1.01億元。不計手續費,每手200股,賬面賺990元。
康德萊是內地領先心內介入器械製造商,公司主要產品(包括球囊擴張壓力泵、導管鞘套裝、造影導絲、動脈壓迫止血帶、Y型連接器套裝、壓力延長管、三通旋塞及造影導管)主要用於心血管介入手術(特別是PCI手術)。根據弗若斯特沙利文,按2018年銷售收入計,康德萊於內地PCI支援器械及冠狀動脈介入器械市場的國產品牌中分別排名第一及第二。
是次來港上市共發售4,000萬股H股,並已引入Worldwide Healthcare Trust及專注醫療保健投資的私募基金OrbiMed為基石投資者,合共認購1,131.28萬股;其中10%公開發售獲近267倍超購,已啟動回撥機制佔比增至50%,認購一手中籤率30%;股份以招股範圍(20.1-20.8元)上限定價,料集資淨額7.58億元,主要用作上海市嘉定區研發中心和額外生產設施、開發現有管線產品並將其商業化、購買額外生產設備並替換現有生產設備和將生產線自動化、擴大康德萊的分銷網絡和覆蓋範圍及為潛在戰略投資提供資金等。上市獨家保薦人交銀國際。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.